Soleus Capital Management, L.P.
Top Portfolio Positions
93 positions ·
$2,469,218,398 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| KRYS |
Krystal Biotech, Inc.
Healthcare
|
1,153,087 | $297,865,433 | 12.06% | |
| CELC |
Celcuity Inc.
Healthcare
|
1,284,378 | $146,598,904 | 5.94% | |
| TGTX |
Tg Therapeutics, Inc.
Healthcare
|
4,029,319 | $133,853,977 | 5.42% | |
| PODD |
Insulet Corp
Healthcare
|
562,500 | $118,035,000 | 4.78% | |
| NVCR |
NovoCure Ltd
Healthcare
|
10,492,391 | $114,367,061 | 4.63% | |
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
187,187 | $110,998,147 | 4.50% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
330,517 | $106,489,272 | 4.31% | |
| VCEL |
Vericel Corp
Healthcare
|
2,549,079 | $82,003,871 | 3.32% | |
| ALKS |
Alkermes plc.
Healthcare
|
1,970,864 | $69,689,751 | 2.82% | |
| ANIP |
Ani Pharmaceuticals Inc
Healthcare
|
820,243 | $63,076,686 | 2.55% |
Portfolio Trend
25 quarters · across all stocks
Holdings in KRYS
Shares Held
Position Value (USD)
22 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $297,865,433 | 1,153,087 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $232,008,685 | 941,059 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $179,854,236 | 1,018,831 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $126,869,806 | 922,958 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $79,648,967 | 441,758 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $56,143,654 | 358,379 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $39,496,687 | 216,979 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $23,138,640 | 126,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $14,963,913 | 84,100 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,962,400 | 40,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $13,675,472 | 117,892 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $12,936,540 | 110,192 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,819,430 | 85,179 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $14,910,550 | 188,217 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $14,451,040 | 207,332 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $14,082,888 | 214,482 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $19,252,483 | 289,337 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $15,979,168 | 228,437 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $6,553,869 | 125,529 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $4,591,972 | 67,529 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $12,853,661 | 166,844 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $625,380 | 10,423 | Shares | Sole | 2021-04-29 | |
| No 13F history on record for this holder in this stock. | ||||||